Note from the MD: Higher terminal rate forecast while market weighs risk

Yesterday’s 25 basis point rate hike was largely expected by economists, but it was RBA governor Philip Lowe’s outlook of a 3.85% terminal cash rate that slightly stunned the market – with Australian equities pulling back and the dollar spiking. The ASX 200 was less than 1% off it’s all time high on Monday, but has since retreated to 1.5% away from its April 2022 record.

Yesterday’s 25 basis point rate hike was largely expected by economists, but it was RBA governor Philip Lowe’s outlook of a 3.85% terminal cash rate that slightly stunned the market – with Australian equities pulling back and the dollar spiking. The ASX 200 was less than 1% off it’s all time high on Monday, but has since retreated to 1.5% away from its April 2022 record.

Australian Banking Association Chief Executive Anna Bligh says that talks of a mortgage cliff are unhelpful, but there are over 800,000 households that are due to come off fixed interest loans this year at roughly 3% and will become variable loans of around 6.4%. Sydney house prices are now down almost 14% over the past year, and Melbourne’s are down over 9% in the same time period.

Australia’s largest gold miner, Newcrest Mining (ASX: NCM) is being targeted by it’s old parent Newmont Corporation (NYSE: NEM) in a $24.4 billion acquisition that has put gold M&A firmly back in the market’s sights. An interesting debate has been sparked as to whether there is more value in either splitting up Newcrest’s assets or selling the entire company at this price, and whether growing bigger for the sake of it is even really a strategy.

The XJO has hit a roadblock at resistance 7558, failing to build on recent gains. However, the 50-day MA remains above the 200-day MA, signaling further upside potential. 

Implied Volatility has declined, near 52-week lows, supporting a bullish market outlook.

Debit trades are a favorable option in the current low volatility environment, offering the potential for increased volatility and market movements. This is a good time to consider cheap options, whether long or short, depending on your investment outlook.

In what has been a rare occurrence as of late, there was a biotech IPO in the US that came on excitingly strong. Structure Therapeutics raised US$161 million in an upsized deal at US$15 per share, with the company’s stock surging 73% on the first trading day. It’s a welcome risk on signal by the market, as investors eagerly watch to see if the IPO window will open again this year. As at 7 February, the Nasdaq is up over 15% so far this year.

We have an upcoming webinar with a company targeting Australia’s 2.4 million small businesses, many of which have been alienated by large banks and their slow processes when it comes to getting a loan.

Propell Holdings Limited (ASX: PHL) has an AI-enabled digital-first approach to providing financing to small companies making it fast and easy for them to access the capital they need to grow. With over 2,600 customers onboarded, growing fast and with a clear pathway to profitability.

Tomorrow at 12pm (AEDT) we will be joined by Propell CEO Michael Davidson for what we think will be a fascinating conversation for potential investors about Propell’s offering, achievements over the past year and business plans for the future. Click here to attend.

 

Reach Markets have been engaged by Propell Holdings Ltd and may receive fees for its services.

Past performance is not a reliable indicator of future performance.

Any advice contained in this communication is general only and does not consider your objectives, financial situation or needs, and you should consider whether it is appropriate for you. This might mean that you need to seek personal advice from a representative authorised to provide personal advice. If you are thinking about acquiring a financial product, you should consider our Financial Services Guide (FSG) including the Privacy Statement at www.reachmarkets.com.au and the relevant Product Disclosure Statement, Prospectus or offer documents to understand the features, risks and returns associated with the investment.

Reach* may have a material interest in and may earn fees or brokerage from any securities referred to in business or in which we seek to do business with. Please refer to the relevant offer documents for full details.

Trading options is not suitable for everyone. There is a risk that you can lose more than the value of a trade or its underlying assets. You should only act on the information we provide if you are confident that you fully understand what you are doing. Past returns do not always indicate future returns, and it is also possible to make significant losses. There is always a risk of loss when trading and investing.

*Reach refers to Reach Markets Pty Ltd (ABN 36 145 312 232) (CAR No: 431191), Reach Corporate Pty Ltd (ABN 76 638 960 540) (CAR No:1281636), Reach Trading Pty Ltd (ABN 16 615 714 442) (CAR No.1265855) of Reach Financial Group Pty Ltd (ABN 17 090 611 680) who hold an Australian Financial Services Licence (AFSL) 333297.

Sources:

 

This Week’s News

News

22 November 2023

Rare Earths Industry Review: Part 2

News

22 November 2023

Rare Earths Industry Review

News

22 November 2023

World first left ventricle heart failure device gears up for approval

General Advice Warning

Any advice provided by Reach Markets including on its website and by its representatives is general advice only and does not consider your objectives, financial situation or needs, and you should consider whether it is appropriate for you. This might mean that you need to seek personal advice from a representative authorised to provide personal advice. If you are thinking about acquiring a financial product, you should consider our Financial Services Guide (FSG)

including the Privacy Statement and any relevant Product Disclosure Statement or Prospectus (if one is available) to understand the features, risks and returns associated with the investment.

Please click here to read our full warning.